Results 191 to 200 of about 6,154,680 (249)

РезÑлÑÑаÑи повÑоÑÐ½Ð¸Ñ Ð½ÐµÐ¹ÑоÑÑÑÑÑгÑÑÐ½Ð¸Ñ Ð²ÑÑÑÑÐ°Ð½Ñ Ð¿Ñи ÑÑÐ°Ð²Ð¼Ñ Ð¿ÐµÑиÑеÑиÑÐ½Ð¸Ñ Ð½ÐµÑвÑв нижнÑÑ ÐºÑнÑÑвок.

, 2013
В. І. Цимбалюк, М. М. Татарчук   +1 more
openalex   +2 more sources

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

Molecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Lorena Ligammari, Georgina Wherry, Giorgia Gaeta, John C. Christianson, Adrienne M. Flanagan, Udo Oppermann, Adam P. Cribbs   +11 more
wiley   +1 more source

HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study. [PDF]

PLoS One
Bentley AR, Ntabadde K, Kabeza CB, Ekoru K, DuBose CW, Sacks DB, Adeyemo AA, Rotimi CN, Sumner AE.   +8 more
europepmc   +1 more source

« ‚ßÔÎ ×ð´ ×ñ˜æè Öæß

, 2013
àææçÜ×æ ÌÕSâä×
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Impact of vitamin D non-reimbursement policy on therapy discontinuation in the general and rheumatic population in the Netherlands: a cross-sectional study. [PDF]

BMJ Open
Singh A, Huiskes VJB, van den Bemt BJF, van Ameijden H, Nurmohamed MT, Spijkers KM, Vervloet M, Brabers AEM.   +7 more
europepmc   +1 more source

ÐÑкÑÐ²Ð°Ð½Ð½Ñ Ñ Ð¿ÑоÑÑлакÑика гнÑйно-ÑепÑиÑÐ½Ð¸Ñ ÑÑÐºÐ»Ð°Ð´Ð½ÐµÐ½Ñ Ñа ÑÑоÑепÑиÑÑ Ð¿ÑÑÐ»Ñ Ð´Ð¸ÑÑанÑÑÐ¹Ð½Ð¾Ñ Ð»ÑÑоÑÑипÑÑÑ.

, 2013
С. І. Баранник, І. Д. Крижановський, І. Б. Білий, А. С. Бараннік   +3 more
openalex   +2 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Vitamin D Deficiency as a Risk Factor for Onset and Recurrence of Sudden Sensorineural Hearing Loss: A Prospective Cohort Study With Age-Specific Analysis. [PDF]

Food Sci Nutr
Hui Q, Xiang T, Qinglan X, Shuowei Y, Mengshi C, Qin X, Hongyin L, Juntao Y, Yunping F.   +8 more
europepmc   +1 more source